戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (right1)

通し番号をクリックするとPubMedの該当ページを表示します
1 ulations showing that the lifetime of the putative reactive NO(2) dimer on the surface of pure water droplets is too smal
2  scenarios for possible responses to the COVID-19 pandemic: no action, mitigation for 6 months, suppression for 2 months,
3 on, while an equal volume of saline was administered in the no-anticoagulation group.
4             Scopolamine was used in 34 FVE and 24 CAE, with no association to AV complete visualization rates (p = 0.30 a
5                                                             No association was seen between high aFXa and 90-day clinical
6 ions, including early hypermotor signs, early recovery, and no aura from posterior insula features of early dystonia, ear
7 son Comorbidity Index, diabetes or obesity when compared to no-CCY (all P > 0.05), but were less likely to have a previou
8                                        Our results indicate no clear link between coral age and microbial diversity or ri
9 ween catchments and in individual populations, but there is no clear link to estrogen pollution.
10                                          However, there was no consensus on the relevance of REA, including how each of t
11                                                             No deaths or cases of inflammatory bowel disease were reporte
12                                                    There is no definitive neural marker of suicidal thoughts and behavior
13                           If these frequencies are removed, no delay is perceived.
14                                                   There was no difference in adverse events between randomised groups.
15 t satisfaction with breast appearance were high with either no difference or better outcome in the 40-Gy cohort compared
16                                                   There was no discordance when all the echocardiographic parameters agre
17                                        Similarly, there was no dose-dependent relationship between PPS exposure and diagn
18 sing the CdS shell volume through the length elongation has no effect on either the peak wavelength or intensity of the C
19  partially downregulated mTOR pathway activation but showed no effect on viability.
20 collagen II immunostaining in undamaged DDH cartilage, with no evidence of augmented cell death by activation of caspase
21 hoto-identification and telemetry studies, our results show no evidence of population structure (non-significant F(ST) <
22  resources, climate, and biogeochemical processes; however, no global snow drought assessments currently exist.
23 t in which it occurs, with artifact in one quadrant showing no impact on DeltaRNFL in the opposite quadrant (P > 0.05).
24                                                    However, no in-depth study is currently available that has investigate
25                                                             No interference was observed in presence of 100 ppb arsenic,
26                                Solvolytic rate studies show no large rate enhancements due to the t-butyl group in 7.
27                     The required metabolic changes are also no less complex than those observed for multiple other of the
28                                   In contrast to phosphors, no light conversion is required as the diffuser relies solely
29 ation performance obtained for large variations in size was no lower than that obtained for smaller variations in size.
30 esian methods (LSD, TreeTime, and treedater), we found that no method performed the best in every scenario.
31  from Jak2V617F mice resulting from a disturbed endothelial NO pathway and increased endothelial oxidative stress.
32 ntly lower rate and hazard of MACE at 5 years compared with no PCI (31.5% vs 39.1%; hazard ratio, 0.77 [95% CI, 0.63-0.94
33                                     A 37-year-old male with no relevant history presented to the Emergency Room with acut
34                                                             No responses were observed with ATM or CHEK2 mutations alone.
35 ent data and BCAR episodes from all six CTG trials revealed no safety concerns when compared with the RGT.
36 , at least in members examined to date, whereas G3 exhibits no sequence-specific insertion.
37                                                   There was no significant association between donor MDRO and either meas
38  of worms/fish) over a 53 year period from 1962 to 2015 and no significant change in Pseudoterranova spp. abundance over
39                                                             No significant difference in the risk of cardiovascular death
40                                        Similarly, there was no significant difference within different types of glaucoma,
41                                                   There was no statistically significant difference in readmission rates.
42                                         However, there were no statistically significant differences in handgrip strength
43 mortality (HR, 0.83 [95% CI, 0.75-0.92]), whereas there was no statistically significant mortality reduction with prasugr
44 s first described by our group in 2006, and there have been no subsequent reports of outcomes with this technique.
45  human studies, GFAP, was highest at 6 h post-injury, while no substantial changes were observed in UCH-L1, Iba-1 or IL-6
46                                                    However, no such asymmetry was observed in assays performed in the pre
47                                                             No thrombotic complications were reported under DOAC until la
48                                                  Currently, no treatment options are available to establish remyelination
49                                                  There were no unexpected adverse events with (177)Lu-PSMA retreatment.
50 to those injected with Cas9 protein (94.2%), with little to no unintended off-target mutations detected.